Beta Bionics Affirms FY2026 Sales Guidance of $131.000M-$136.000M vs $133.305M Est
Beta Bionics (NASDAQ: BBNX ) affirms FY2026 sales outlook from $131.000 million-$136.000 million to $131.000 million-$136.000 million vs $133.305 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.